ALL-in-1
0864.603.461 · rovalta.com · 25/09/2026
ALL-in-1
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOALL-in-1 is a Private limited company incorporated in 2004. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Schelle. It employs on average 18,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0864.603.461
- Incorporation
- 08/04/2004
- Legal form
- Private limited company
- Registered office
- Molenberglei 36
2627 Schelle · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
- Average workforce
- 18,7 ETP
Joint committees (8)
- 116
- 1160
- 200
- 2000
- 207
- 2070
- 314
- 321
Financials
Source · NBB, 22 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 26,3 M € | -24.7% | 35 M € | -8.0% | 38 M € | -10.3% | 42,4 M € | -6.0% | 45,1 M € |
| EBITDA | 271,5 k € | +46.5% | 185,3 k € | +2154% | 8,2 k € | -92.3% | 106,6 k € | +81.2% | 58,8 k € |
| Operating result | 161,3 k € | +122% | 72,7 k € | +193% | -77,8 k € | -508% | 19,1 k € | +198% | 6,4 k € |
| Net result | -66,1 k € | -195% | 69,5 k € | +277% | 18,5 k € | +178% | 6,6 k € | -22.7% | 8,6 k € |
| Balance sheet | |||||||||
| Equity | 109,1 k € | -37.7% | 175,1 k € | +65.8% | 105,6 k € | +21.2% | 87,2 k € | +158% | 33,8 k € |
| Total assets | 9 M € | -20.4% | 11,3 M € | +2.0% | 11,1 M € | -4.2% | 11,5 M € | +2.9% | 11,2 M € |
| Cash | 397 k € | -37.8% | 638,7 k € | +87.3% | 341 k € | -77.8% | 1,5 M € | +347% | 344,3 k € |
| Debts | 8,8 M € | -20.2% | 11,1 M € | +1.1% | 10,9 M € | -4.4% | 11,4 M € | +2.4% | 11,2 M € |
| Other | |||||||||
| Workforce | 18,7 ETP | -17.3% | 22,6 ETP | +6.6% | 21,2 ETP | +5.0% | 20,2 ETP | +1.0% | 20,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/2025Other companies at this address
Molenberglei 36 2627 Schelle| Company | CBE no. |
|---|---|
AMOPHAR● Active | 0839.385.540 |
Amophar OTC● Active | 0795.483.142 |
INPHAGRO● Active | 0664.787.322 |
KDT Consulting● Active | 0877.577.806 |
LIFE MEDICAL● Active | 0561.721.456 |
WOLFMAN● Active | 0750.605.497 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/01/2026 | 09/07/2025 | 22/03/2024 | 11/01/2023 | 31/01/2022 | 31/12/2020 |
| General meeting | 23/01/2026 | 20/12/2024 | 15/03/2024 | 22/12/2022 | 28/01/2022 | 08/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 22 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 30/06/2025 | 23/01/2026 | 30/01/2026 | Dutch | |
| Full model | 30/06/2024 | 20/12/2024 | 09/07/2025 | Dutch | |
| Full model | 30/06/2023 | 15/03/2024 | 22/03/2024 | Dutch | |
| Full model | 30/06/2022 | 22/12/2022 | 11/01/2023 | Dutch | |
| Full model | 30/06/2021 | 28/01/2022 | 31/01/2022 | Dutch | |
| Full model | 30/06/2020 | 08/12/2020 | 31/12/2020 | Dutch | |
| Full model | 30/06/2019 | 10/12/2019 | 21/01/2020 | Dutch | |
| Full model | 30/06/2018 | 11/12/2018 | 19/12/2018 | Dutch | |
| Full modelCorrection | 30/06/2017 | 12/12/2017 | 30/05/2018 | Dutch | |
| Full modelCorrection | 30/06/2017 | 12/12/2017 | 26/04/2018 | Dutch | |
| Full model | 30/06/2017 | 12/12/2017 | 30/12/2017 | Dutch | |
| Full model | 30/06/2016 | 30/11/2016 | 16/12/2016 | Dutch | |
| Full model | 30/06/2015 | 23/11/2015 | 01/12/2015 | Dutch | |
| Full model | 30/06/2014 | 15/11/2014 | 10/12/2014 | Dutch | |
| Full model | 30/06/2013 | 24/10/2013 | 18/12/2013 | Dutch | |
| Full model | 30/06/2012 | 24/12/2012 | 03/01/2013 | Dutch | |
| Abridged model | 30/06/2011 | 25/12/2011 | 25/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 20/12/2010 | 29/12/2010 | Dutch | |
| Abridged model | 30/06/2009 | 14/12/2009 | 30/12/2009 | Dutch | |
| Abridged model | 30/06/2008 | 16/09/2008 | 21/09/2008 | Dutch | |
| Abridged model | 30/06/2007 | 11/12/2007 | 29/01/2008 | Dutch | |
| Abridged model | 30/06/2006 | 12/12/2006 | 19/01/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/2025Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates03/11/2025ONTSLAGEN - BENOEMINGEN
- Mandates10/01/2023ONTSLAGEN - BENOEMINGEN
- Mandates19/02/2021ONTSLAGEN - BENOEMINGEN
- Other10/06/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Mandates31/01/2019ONTSLAGEN - BENOEMINGEN
- Other21/12/2018DOEL
- Mandates06/06/2018DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Mandates23/06/2017ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-66,1 k €↓
- 2024Annual accounts 202469,5 k €↑
- 2024Name changeALL-in-1
- 2023Annual accounts 202318,5 k €↑
- 2022Annual accounts 20226,6 k €↓
- 2022Name changeAll-in1
- 2020Annual accounts 20208,6 k €↑
- 2019Annual accounts 2019-49,8 k €↓
- 2018Annual accounts 201840,8 k €↑
- 2017Annual accounts 201712,7 k €↓
- 2016Annual accounts 2016292,8 k €↓
- 2015Annual accounts 2015378,7 k €↑
- 2014Annual accounts 2014254,3 k €↑
- 2013Annual accounts 201367 k €↓
- 2012Annual accounts 2012246,4 k €↑
- 2011Annual accounts 201148,4 k €↑
- 2010Annual accounts 2010-25,9 k €↓
- 2009Annual accounts 2009-8,2 k €↓
- 2008Annual accounts 20089,3 k €
- 08/04/2004IncorporationPrivate limited company